Katsuhiko Hagi
- Biological Psychiatry top 1%
- Tryptophan and brain disorders 5
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment 18
- Bipolar Disorder and Treatment 13
- Electroconvulsive Therapy Studies 8
- Attention Deficit Hyperactivity Disorder 5
- Pharmacology top 2%
- Treatment of Major Depression 6
- Philosophy top 1%
- Behavioral Neuroscience top 10%
-
- Diabetes Treatment and Management 6
-
- Pharmaceutical studies and practices 4
- Co-authors
- Christoph U. CorrellJohn M. KaneTaishiro KishimotoShin‐ichi MuramatsuShunya KurokawaK InabaR M SteinmanSusumu Ikehara
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Blood (1 paper)Biological Psychiatry (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Katsuhiko Hagi
34 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Biological Psychiatry 293
- Psychiatry and Mental health 962
- Pharmacology 423
- Philosophy 214
- Behavioral Neuroscience 58
Countries citing papers authored by Katsuhiko Hagi
This map shows the geographic impact of Katsuhiko Hagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuhiko Hagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuhiko Hagi more than expected).
Fields of papers citing papers by Katsuhiko Hagi
This network shows the impact of papers produced by Katsuhiko Hagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuhiko Hagi. The network helps show where Katsuhiko Hagi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katsuhiko Hagi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 3 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 7 | |
| 9 | Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studiesbreakdown → | 2021 | 209 |
| 10 | 2021 | 18 | |
| 11 | 2020 | 7 | |
| 12 | 2020 | 8 | |
| 13 | 2017 | 129 | |
| 14 | 2016 | 28 | |
| 15 | 2016 | 108 | |
| 16 | 2016 | 273 | |
| 17 | 2015 | 17 | |
| 18 | 2015 | 13 | |
| 19 | 2005 | 12 | |
| 20 | 1994 | 50 |
About Katsuhiko Hagi
Katsuhiko Hagi is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (8 papers), Diabetes Treatment and Management (6 papers), Treatment of Major Depression (6 papers), Attention Deficit Hyperactivity Disorder (5 papers), Tryptophan and brain disorders (5 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Biological Psychiatry (293 citations), Psychiatry and Mental health (962 citations) and Pharmacology (423 citations). Katsuhiko Hagi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Christoph U. Correll, John M. Kane, Taishiro Kishimoto, Shin‐ichi Muramatsu, Shunya Kurokawa, K Inaba, R M Steinman, Susumu Ikehara, Masashi Deguchi and Muneo Inaba. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Biological Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.